Effect of low-dose exogenous surfactant on infants with acute respiratory distress syndrome after cardiac surgery: a retrospective analysis

Table 2 Clinical outcomes (in 30 days)

Characteristic	Surfactant n = 22	Control n = 22	P Value
Alive/death (n/n)	22/0	22/0	–
Complication
Pneumothorax (%)	2(9)	5(22.7)	0.001
Digestive tract hemorrhage (%)	0(0)	1(4.5)	0.000
Rescue treatment (%)
CPAP (%)	3(13.6)	8(36.3)	0.015
Re tracheal intubation (%)	1(4.5)	2(9)	0.000
PD (%)	1(4.5)	2(9)	0.000
HFOV (%)	0(0)	1(4.5)	0.000
Total time on ventilator (h)	133.6 ± 27.2	218.4 ± 28.7	0.000
Total time in PICU (day)	10.7 ± 5.1	17.5 ± 6.8	0.001

Surfactant: patients who had ARDS after cardiac surgery received standard treatment plus exogenous surfactant. Control: patients who had ARDS after cardiac surgery received standard treatment only. The data are presented as mean ± standard; qualitative data are presented as numbers (%)
CPAP treatment with continuous positive airway pressure, PD treatment with peritoneal dialysis, HFOV treatment with high frequency oscillatory ventilator

ISSN: 1471-2466